An exciting new clinical trial has just been announced in America. This innovative new research project aims to investigate the potential use of cord blood stem cells in the treatment of paediatric strokes.
We take some time to talk to Nathan Walker, who discusses the trial in more detail.
America’s largest family cord blood bank; the Cord Blood Registry (CBR), has just announced the launch of a new clinical trial to investigate the potential of a child’s own cord blood to treat strokes.
Unfortunately, the majority of the children that survive this trauma experience neurological defects which could potentially lead to paralysis, epilepsy as well as loss of bladder control.This latest clinical trial will be conducted at the Florida Hospital for Children and will involve ten children between the ages of six months and six years, all of whom will have experienced a stroke in the womb or immediately after birth.Each of the children will be experimentally treated by infusing their own cord blood, which was previously collected and stored after birth. The children will then be assessed for improvements in brain function, epilepsy evaluation, nerve function and bladder control issues for a period of 12 months.It is hoped that the preliminary results of this trial will be available within less than three years. This is the first clinical trial that investigates the potential uses of new-born autologous stem cell therapy in the treatment of paediatric strokes.”
This is a very exciting advancement in autologous stem cell therapy, to discover which other illnesses can presently be treated using umbilical cord stem cells simply visit: Cord blood and cord tissue cell banking
Alternatively, for more information on this fascinating new trial read this article.